respiratory medical device News
-
COVID-19 Respiratory Monitoring with MediPines AGM100 in Long-Term Care Facilities
Long-term care facilities are facing extraordinary challenges with the devastating and often undetectable presence of COVID-19. Elderly and at-risk residents in retirement homes and assisted living facilities are more likely to suffer with comorbidities which can impact the severity and mortality of those with COVID-19. To meet this growing challenge in the face of rising pandemic, MediPines, a ...
By MediPines
-
Finalists Announced for the 2020 Georgia Healthcare Innovation Challenge (Media Advisory)
WHAT: September 14th, 2020 - Navicent Health, in partnership with Atlanta Tech Village, Georgia HIMSS and TAG Digital Health, has announced the finalists for the 2020 Georgia Healthcare Innovation Challenge (GHIC). Launched in July of 2020, this challenge aims to foster collaboration between medical and technology providers to improve the delivery of healthcare in Georgia. On July 30th, Navicent ...
-
Study Finds MediPines’ Breakthrough Non-invasive Gas Exchange Method Highly Precise: Ideal for Covid Response
A recent clinical study published by medical researchers from UC San Diego School of Medicine has established that an expired breath sampling method is comparable to the long-established blood-based method (ABG) of measuring pulmonary gas exchange efficiency. Published in the American Journal of Physiology Lung Cellular and Molecular Physiology, the study, entitled “Measuring the ...
By MediPines
-
MediPines Wins Prestigious Pediatric Medical Device Competition Focused on COVID-19-Related Technologies
MediPines, a respiratory medical device company, was selected a winner in the special COVID-19 edition of the “Make Your Medical Device Pitch for Kids!” competition presented by FDA-sponsored National Capital Consortium for Pediatric Device Innovation. The competition focused on innovations in COVID-19-related pediatric medical devices that will improve children’s health care, ...
By MediPines
-
Liberate Medical Reports Positive Pilot Trial Results of VentFree Respiratory Muscle Stimulator
Applying non-invasive electrical stimulation to the expiratory abdominal muscles may reduce abdominal muscle atrophy and markedly reduce the number of days adult patients require mechanical ventilation – a potentially important finding for weaning ventilated patients, including seriously ill COVID-19 patients, and improving patient outcomes. Liberate Medical today announced the results of ...
-
Fluidda and Aptar Pharma Exclusive Collaboration
Fluidda, leader in the field of Functional Respiratory Imaging and developer of the medical device Broncholab®, today announced an exclusive collaboration with Nanopharm, an Aptar Pharma company and a leader in contract research and development services for orally inhaled and nasal drug products (OINDPs). The companies will leverage their respective proprietary technology platforms to help ...
By Fluidda
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you